MedPath

IRCCS SAN RAFFAELE ROMA SRL

🇮🇹Italy
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.poliambulatorisanraffaele.it/it/sedi/san-raffaele-pisana

SARS-CoV-2, TESTOSTERONE AND MALE FRAGILITY

Recruiting
Conditions
COVID-19
Infertility, Male
Testosterone Deficiency
Interventions
Diagnostic Test: Collection of biological data
First Posted Date
2023-12-20
Last Posted Date
2023-12-20
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
2000
Registration Number
NCT06177002
Locations
🇮🇹

IRCCS Ospedale San Raffaele, Milan, Lombardy, Italy

Radiation Treatment of Lymph Node Recurrence From Prostate Cancer : is 11C-choline PET/CT Predictive of Survival Outcomes?

Completed
Conditions
Prostate Cancer
First Posted Date
2023-12-14
Last Posted Date
2023-12-14
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
68
Registration Number
NCT06170164
Locations
🇮🇹

Irccs San Raffaele, Milano, Italia, Italy

Role of18F-FDG PET-CT for Assessing and Predicting Response to Daratumumab and for Prognosis With Multiple Myeloma

Completed
Conditions
Multiple Myeloma
First Posted Date
2023-12-14
Last Posted Date
2023-12-14
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
10
Registration Number
NCT06170151
Locations
🇮🇹

Irccs San Raffaele, Milano, Italia, Italy

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Recruiting
Conditions
Bladder Cancer Stage IIIb
Urinary Diversion
Muscle Invasive Bladder Urothelial Carcinoma
Bladder Cancer Stage IV
Bladder Cancer Stage II
Bladder Cancer Stage IIIc
Progression, Disease
Bladder Cancer Stage IIb
Bladder Leiomyosarcoma
Bladder Cancer Stage IIIa
Interventions
Procedure: Radical Cystectomy
First Posted Date
2023-12-14
Last Posted Date
2023-12-14
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
4000
Registration Number
NCT06170177
Locations
🇮🇹

IRCCS Ospedale San Raffaele, Milan, MI, Italy

Prognostic Value of Pre-therapy 18F-FDG PET/CT for the Outcome of 18 FDG PET-guided SIB-IMRT in Patients With Head and Neck Cancer

Completed
Conditions
Head and Neck Cancer
First Posted Date
2023-12-14
Last Posted Date
2023-12-14
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
19
Registration Number
NCT06171464

Prognostic Values of PET Examination With 11 C-Fe_CIT With Voxel-based Analysis Method in Patients With Sporadic Parkonson's Disease and Parkinsonisms (Prot.PD-diagn).

Completed
Conditions
Parkinson Disease
First Posted Date
2023-12-14
Last Posted Date
2023-12-14
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
300
Registration Number
NCT06171451

Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.

Completed
Conditions
Lung Cancer
First Posted Date
2023-12-13
Last Posted Date
2023-12-13
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
30
Registration Number
NCT06168877

The Long-term Course of Moderate Tricuspid Regurgitation

Completed
Conditions
Tricuspid Regurgitation
Echocardiography
Heart Failure
First Posted Date
2023-12-13
Last Posted Date
2023-12-13
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
250
Registration Number
NCT06169345
Locations
🇮🇹

Irccs San Raffaele, Milan, Italy

Translational Cancer Observational Protocol

Recruiting
Conditions
Upper Urinary Tract Urothelial Carcinoma
Interventions
Procedure: Nephroureterectomy
First Posted Date
2023-12-13
Last Posted Date
2023-12-13
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
1250
Registration Number
NCT06169436
Locations
🇮🇹

IRCCS Ospedale San Raffaele, Milan, MI, Italy

Multidetector CT Left Appendage Atrial Thrombosis Exclusion in Patients With Atrial Fibrillation

Completed
Conditions
Atrial Fibrillation
First Posted Date
2023-12-13
Last Posted Date
2023-12-13
Lead Sponsor
IRCCS San Raffaele
Target Recruit Count
260
Registration Number
NCT06169332
© Copyright 2025. All Rights Reserved by MedPath